GlassScriptPhysician profile
Isaac Perez
NPI 1962400937
$14,292.96
in general payments reported to CMS, 2019-2025
38 companies · $2,518 in 2025
The $2,518 reported for 2025 was more than what 81% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,967 · 2020: $1,736 · 2021: $1,631 · 2022: $1,562 · 2023: $2,232 · 2024: $2,647 · 2025: $2,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,073 · Education: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,073.22 |
| Education | $323.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,504.29 | 2019-2025 | |
| Janssen Biotech, INC. | $1,565.52 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Mayne Pharma Commercial LLC | $1,106.19 | 2019-2025 | |
| Pfizer INC. | $820.49 | 2019-2025 | |
| Ucb, INC. | $788.27 | 2019-2025 | Bimzelx, Cimzia |
| Sun Pharmaceutical Industries INC. | $722.44 | 2019-2025 | Winlevi, Absorica Ld |
| Novartis Pharmaceuticals Corporation | $664.12 | 2019-2025 | |
| Galderma Laboratories, L.P. | $659.15 | 2019-2025 | Oracea, Aklief, Epsolay |
| Incyte Corporation | $566.32 | 2022-2025 | Opzelura |
| Amgen INC. | $510.75 | 2023-2025 | Otezla, Otezla |
| Vyne Pharmaceuticals INC. | $503.28 | 2020-2021 | |
| Arcutis Biotherapeutics, INC. | $467.86 | 2023-2025 | Zoryve |
| Lilly USA, LLC | $440.02 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Dermavant Sciences, INC. | $396.90 | 2023-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $359.13 | 2019-2025 | Arazlo, Cabtreo |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.